US Stock Options Smash Record, Surpassing 10 Billion Contracts

image

(Bloomberg) — The boom in stock market options shows no sign of let up, as the number of traded US contracts surpassed the 10-billion mark in 2022 for the first time ever, playing a role in the biggest equity rout in over a decade

For the third straight year, contracts in US single-stock and index options set a record, more than doubling from the level three years ago.

The options frenzy was a major feature in a year when the Nasdaq 100 Index fell 33% and the S&P 500 shed 20%.

As the mood soured, trading in “puts” — contracts allowing holders to sell — soared by more than 30% compared to 2021, while that in bullish “call” options declined 12%.

Another feature was the explosive growth in very short-term contracts, sometimes maturing within 24 hours. Pinpointing exact volumes can be tricky but S&P 500 options expiring within one day comprised more than 40% of total volume over the third quarter, almost doubling from six months before, Goldman Sachs estimated.

This short-dated option market is increasingly drawing professional traders and algorithmic-powered institutions, especially around crucial data releases or central bank press conferences. With holders going in and out in a flash, such options are seen by many as contributing to volatility.

However, despite the overall record, year-on-year growth in options trading slowed, after rising by a third in 2021 and by a whopping 50% the year before.

The outsize increases of 2021 and 2020 are attributed to small-fry retail traders whose interest in tech shares and so-called meme stocks such as GameStop Corp. sparked huge demand for leveraged investments such as options and other derivatives. But during a year of steep equity losses, many of those participants were likely put to flight.

©2022 Bloomberg L.P.

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More